We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.95B
AUM Growth
-$232M
(-4.5%)
Cap. Flow
-$467M
Cap. Flow
% of AUM
-9.44%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,100
New
153
Increased
294
Reduced
399
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$28.6M |
| 2 |
Intuit
INTU
|
+$27.6M |
| 3 |
Electronic Arts
EA
|
+$23.2M |
| 4 |
Qualcomm
QCOM
|
+$22.5M |
| 5 |
Chevron
CVX
|
+$19.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$41.2M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$37.2M |
| 4 |
Advanced Micro Devices
AMD
|
+$26.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.09% |
| 2 | Financials | 17.69% |
| 3 | Healthcare | 13.21% |
| 4 | Industrials | 12.31% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Clorox
CLX
$11.6B
| $294K | 0.01% |
+2,180
| New | +$282K |
|
727
LSI Industries
LYTS
$853M
| $294K | 0.01% |
+29,150
| New | +$283K |
|
728
Karyopharm Therapeutics
KPTI
$168M
| $292K | 0.01% |
1,516
-1,391
| -48% | -$223K |
|
729
MannKind Corp
MNKD
$1.28B
| $292K | 0.01% |
197,246
+86,440
| +78% | +$227K |
|
730
NETGEAR
NTGR
$669M
| $292K | 0.01% |
5,900
-13,858
| -70% | -$757K |
|
|
SHLO
731
DELISTED
Shiloh Industries Inc
SHLO
| $292K | 0.01% |
21,430
+6,030
| +39% | +$75.4K |
|
|
BRKL
732
DELISTED
Brookline Bancorp
BRKL
| $289K | 0.01% |
18,480
-800
| -4% | -$12.6K |
|
733
Wintrust Financial
WTFC
$10.7B
| $286K | 0.01% |
4,140
| – | – |
|
|
ARNA
734
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $286K | 0.01% |
+19,590
| New | +$290K |
|
735
Asbury Automotive
ABG
$4.19B
| $285K | 0.01% |
+4,750
| New | +$304K |
|
736
Essex Property Trust
ESS
$18.9B
| $283K | 0.01% |
1,224
| – | – |
|
|
SRGA
737
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $283K | 0.01% |
2,354
+1,507
| +178% | +$157K |
|
738
Omnicom Group
OMC
$22.7B
| $278K | 0.01% |
+3,230
| New | +$276K |
|
739
Fate Therapeutics
FATE
$281M
| $276K | 0.01% |
60,704
-33,278
| -35% | -$122K |
|
|
FARO
740
DELISTED
Faro Technologies
FARO
| $269K | 0.01% |
7,530
+400
| +6% | +$14.6K |
|
|
CALA
741
DELISTED
Calithera Biosciences, Inc
CALA
| $269K | 0.01% |
1,166
+63
| +6% | +$10.9K |
|
742
PPG Industries
PPG
$25.9B
| $268K | 0.01% |
2,554
+340
| +15% | +$34.4K |
|
743
Stock Yards Bancorp
SYBT
$2.41B
| $268K | 0.01% |
6,600
| – | – |
|
744
M&T Bank
MTB
$36.2B
| $266K | 0.01% |
+1,716
| New | +$278K |
|
745
Texas Roadhouse
TXRH
$12.7B
| $266K | 0.01% |
+5,970
| New | +$269K |
|
|
TBNK
746
DELISTED
Territorial Bancorp Inc.
TBNK
| $266K | 0.01% |
8,540
-1,760
| -17% | -$56.8K |
|
747
Markel Group
MKL
$25B
| $264K | 0.01% |
271
-2,886
| -91% | -$2.73M |
|
748
Marchex
MCHX
$79.7M
| $263K | 0.01% |
96,863
-5,000
| -5% | -$13.5K |
|
749
Brink's
BCO
$5.02B
| $257K | 0.01% |
4,800
-4,500
| -48% | -$219K |
|
750
LPL Financial
LPLA
$26.3B
| $256K | 0.01% |
+6,420
| New | +$252K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2017 Portfolio in Review
As of Q1 2017, Jacobs Levy Equity Management held 1,100 positions worth $4.95B, down 4.5% from $5.18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $467M in Q1 2017, closing 191 positions and reducing 399 holdings. Its most notable exit was VMware, Inc, an estimated $22.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Intuit worth $26.7M.
- Jacobs Levy Equity Management's largest Q1 2017 buy was Intuit: 229,923 shares worth $26.7M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q1 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2017 reduction was Amgen, cutting an estimated $41.2M.
- Jacobs Levy Equity Management fully exited VMware, Inc in Q1 2017, selling an estimated $22.6M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $4.95B portfolio in Q1 2017.
- Jacobs Levy Equity Management opened 153 new positions and closed 191 in Q1 2017.
- Jacobs Levy Equity Management's portfolio value fell 4.5% quarter-over-quarter to $4.95B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.